Hypertension, defined as a systolic blood pressure (SBP) of at least 130 mm Hg or diastolic blood pressure (DBP) of at least 80 mm Hg, is a major risk factor for cardiovascular disease (CVD). In the US, approximately 25% of women of reproductive age have hypertension.1 Of these, less than half are aware of their diagnosis and, when diagnosed, only 10% have their blood pressure (BP) controlled.1 Further, racial differences exist, with more than half of Black women aged 20 years or older having hypertension.1 Selecting the appropriate hormonal contraception in women with hypertension is important because several of these contraceptives increase BP and, in those with established hypertension, increase the risk for stroke and myocardial infarction (Figure). This Insights provides guidance in selecting hormonal contraception given that hypertension can be either a relative or absolute contraindication.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Shufelt C, LeVee A. Hormonal Contraception in Women With Hypertension. JAMA. 2020;324(14):1451–1452. doi:10.1001/jama.2020.11935
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: